Recent

% | $
Quotes you view appear here for quick access.

ArQule Inc. Message Board

  • muckfiddler muckfiddler Nov 8, 2012 7:24 AM Flag

    lazard

    really don't get why arql participating. waste of time unless something significant to announce which we all know is not the case. I can't say I'm optimistic about crc...seems like they are not either...barely a mention on last call.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Any company has to do presentations at investor-banker conferences. For ARQL, it is vital to carry a message that they have recovered for the Marquee panic/paralysis and intend to develop their pipeline.
      As for mCRC, let us wait and see. It is a Double Blind trial with pts living more than 2 years.

      • 1 Reply to pharmainvestor11
      • Chan leaving. I do hope this isn't beginning of management exodus. If Arql was a start up, investors would be excited to have a company with a drug going into ph3 in major indication, followed by several significant ph2 trials in progress, about to file a new IND, a solid cash position and experienced management team...(at least they are now!). Would seem like attractive buyout candidate but big pharma will only buy "success" and we don't have that here...yet.

 
ARQL
1.77+0.02(+1.14%)Sep 27 4:00 PMEDT